Anders Blilie

Validation of diagnostic artificial intelligence models for prostate pathology in a Middle Eastern cohort

Abstract Artificial intelligence (AI) for pathology is accelerating cancer diagnostics. For global adoption, studies in currently under-represented populations – where the potential gains from AI may also be greatest – are needed. We present the first external validation study in...